A large number of studies showed that the overexpression of ANLN was detected in various types of cancers, e.g., pancreatic ductal adenocarcinoma, colon, lung, gastric, and hepatocellular carcinoma [33,34,35]. This evidence concerns the gene ANLN and cancer.